作者
Nicholas WS Chew, Cheng Han Ng, Darren Jun Hao Tan, Gwyneth Kong, Chaoxing Lin, Yip Han Chin, Wen Hui Lim, Daniel Q Huang, Jingxuan Quek, Clarissa Elysia Fu, Jieling Xiao, Nicholas Syn, Roger Foo, Chin Meng Khoo, Jiong-Wei Wang, Georgios K Dimitriadis, Dan Yock Young, Mohammad Shadab Siddiqui, Carolyn SP Lam, Yibin Wang, Gemma A Figtree, Mark Y Chan, David E Cummings, Mazen Noureddin, Vincent Wai-Sun Wong, Ronald Ching Wan Ma, Christos S Mantzoros, Arun Sanyal, Mark Dhinesh Muthiah
发表日期
2023/3/7
期刊
Cell Metabolism
卷号
35
期号
3
页码范围
414-428. e3
出版商
Elsevier
简介
Global estimates of prevalence, deaths, and disability-adjusted life years (DALYs) from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019 were examined for metabolic diseases (type 2 diabetes mellitus [T2DM], hypertension, and non-alcoholic fatty liver disease [NAFLD]). For metabolic risk factors (hyperlipidemia and obesity), estimates were limited to mortality and DALYs. From 2000 to 2019, prevalence rates increased for all metabolic diseases, with the greatest increase in high socio-demographic index (SDI) countries. Mortality rates decreased over time in hyperlipidemia, hypertension, and NAFLD, but not in T2DM and obesity. The highest mortality was found in the World Health Organization Eastern Mediterranean region, and low to low-middle SDI countries. The global prevalence of metabolic diseases has risen over the past two decades regardless of SDI. Urgent attention is needed to …
学术搜索中的文章
NWS Chew, CH Ng, DJH Tan, G Kong, C Lin, YH Chin… - Cell Metabolism, 2023